Hennepin Life Sciences

About:

Hennepin Life Sciences is a University of Minnesota spin-out developing treatments for women's health conditions.

Website: http://www.hennepinlifesciences.com/

Description:

Hennepin Life Sciences is a growth stage human and animal health company that is uniquely focused on the development of patent protected, novel, naturally-derived anti-infective compounds for the prevention and treatment of a wide array of infections. We created innovative nature-based therapies by combining molecular concepts of infection to clinical applications.Founded in 2009 from a technology transfer out of the University of Minnesota, Hennepin Life Sciences (HLS) is a Phase2 clinical trial stage, Minnesota -based biotechnology firm that continues to develop a patented approach to address the global super bug challenge. Today, HLS continues to expand its product platform intellectual property, advance the practical science through clinical studies and is active forging distribution partnerships to initially reach clinical application.

Total Funding Amount:

$1.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Plymouth, Minnesota, United States

Founded Date:

2009-01-01

Contact Email:

info(AT)hennepinlifesciences.com

Founders:

Bill Faulkner, Douglas Wicks, Patrick M. Schlievert

Number of Employees:

1-10

Last Funding Date:

2017-03-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai